1. Executive Summary 2. Blood Cancer Drugs Market Characteristics
3. Blood Cancer Drugs Market Trends And Strategies
4. Blood Cancer Drugs Market – Macro Economic Scenario
4.1 COVID-19 Impact On Blood Cancer Drugs Market
4.2 Ukraine-Russia War Impact On Blood Cancer Drugs Market
4.3 Impact Of High Inflation On Blood Cancer Drugs Market
5. Blood Cancer Drugs Market Size And Growth
5.1. Global Blood Cancer Drugs Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Blood Cancer Drugs Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Blood Cancer Drugs Market Segmentation
6.1. Global Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Leukemia
Lymphoma
6.2. Global Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Rituaxan/Mabthera (Rituximab)
Gleevac/Glivec (Imatinib)
Revlimid (Lenalidomide)
Velcade (Bortezomib)
Tasigna (Nilotinib)
Pomalyst (Pomalidomide)
Vidaza (Azacitidine)
Kyprolis (Carfilzomib)
Adcetris (Brentuximab Vedotin)
Other Drugs
6.3. Global Blood Cancer Drugs Market, Segmentation By Treatment Approaches, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Key Findings
Chemotherapeutic
mAbs/Targeted Therapies
Immunotherapeutic
7. Blood Cancer Drugs Market Regional And Country Analysis
7.1. Global Blood Cancer Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Blood Cancer Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8. Asia-Pacific Blood Cancer Drugs Market
8.1. Asia-Pacific Blood Cancer Drugs Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
9. China Blood Cancer Drugs Market
9.1. China Blood Cancer Drugs Market Overview
9.2. China Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
10. India Blood Cancer Drugs Market
10.1. India Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11. Japan Blood Cancer Drugs Market
11.1. Japan Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12. Australia Blood Cancer Drugs Market
12.1. Australia Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13. Indonesia Blood Cancer Drugs Market
13.1. Indonesia Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14. South Korea Blood Cancer Drugs Market
14.1. South Korea Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15. Western Europe Blood Cancer Drugs Market
15.1. Western Europe Blood Cancer Drugs Market Overview
15.2. Western Europe Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16. UK Blood Cancer Drugs Market
16.1. UK Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17. Germany Blood Cancer Drugs Market
17.1. Germany Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18. France Blood Cancer Drugs Market
18.4. France Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.5. France Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19. Eastern Europe Blood Cancer Drugs Market
19.1. Eastern Europe Blood Cancer Drugs Market Overview
19.2. Eastern Europe Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Eastern Europe Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20. Russia Blood Cancer Drugs Market
20.1. Russia Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Russia Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21. North America Blood Cancer Drugs Market
21.1. North America Blood Cancer Drugs Market Overview
21.2. North America Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. North America Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22. USA Blood Cancer Drugs Market
22.1. USA Blood Cancer Drugs Market Overview
22.2. USA Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. USA Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23. South America Blood Cancer Drugs Market
23.1. South America Blood Cancer Drugs Market Overview
23.2. South America Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. South America Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24. Brazil Blood Cancer Drugs Market
24.1. Brazil Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.2. Brazil Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25. Middle East Blood Cancer Drugs Market
25.1. Middle East Blood Cancer Drugs Market Overview
25.2. Middle East Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Middle East Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26. Africa Blood Cancer Drugs Market
26.1. Africa Blood Cancer Drugs Market Overview
26.2. Africa Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. Africa Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27. Blood Cancer Drugs Market Competitive Landscape And Company Profiles
27.1. Blood Cancer Drugs Market Competitive Landscape
27.2. Blood Cancer Drugs Market Company Profiles
27.2.1. Amgen Inc.
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. AstraZeneca PLC
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Bayer AG
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Celgene Corporation
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Eli Lilly
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Blood Cancer Drugs Pipeline Analysis
29. Key Mergers And Acquisitions In The Blood Cancer Drugs Market
30. Blood Cancer Drugs Market Future Outlook and Potential Analysis
31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Historic And Forecast Inflation Rates
31.4. Research Inquiries
31.5. The Business Research Company
31.6. Copyright And Disclaimer